<html><head></head><body><h1>Decitabine</h1><p class="drug-subtitle"><b>Generic Name:</b> decitabine (de SIT a been)<br/><b>Brand Name:</b> <i>Dacogen</i><br/><b>Dosage Forms:</b> intravenous powder for injection (50 mg)</p><ul class="ddc-anchor-links"><li>Uses</li>
<li>Warnings</li>
<li>What to avoid</li>
<li>Side effects</li>
<li>Dosage</li>
<li>Interactions</li></ul><h2 class="ddc-anchor-offset" id="uses">What is decitabine?</h2><p>Decitabine is a cancer medicine that is used to treat myelodysplastic syndromes (certain types of blood or bone marrow cancer).</p><p>Decitabine may also be used for purposes not listed in this medication guide.</p><h2 class="ddc-anchor-offset" id="warnings">Warnings</h2><p>Decitabine affects your immune system. <b>You may get infections more easily, even serious or fatal infections.</b> Call your doctor if you have a fever, chills, cough, mouth sores, or unusual bleeding or bruising.</p><h2>Before taking this medicine</h2><p>Tell your doctor if you have ever had:</p><ul>
<li>
<p>kidney disease; or</p>
</li>
<li>
<p>liver disease.</p>
</li>
</ul><p>kidney disease; or</p><p>liver disease.</p><p>You may need to have a negative pregnancy test before starting this treatment.</p><p>Decitabine can harm an unborn baby or cause birth defects <b>if the mother or the father is using  decitabine.</b></p><ul>
<li>
<p><b>If you are a woman,</b> do not use decitabine if you are pregnant. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 6 months after your last dose.</p>
</li>
<li>
<p><b>If you are a man,</b> use effective birth control if your sex partner is able to get pregnant. Keep using birth control for at least 3 months after your last dose.</p>
</li>
<li>
<p>Tell your doctor right away if a pregnancy occurs while either the mother or the father is using decitabine.</p>
</li>
</ul><p><b>If you are a woman,</b> do not use decitabine if you are pregnant. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 6 months after your last dose.</p><p><b>If you are a man,</b> use effective birth control if your sex partner is able to get pregnant. Keep using birth control for at least 3 months after your last dose.</p><p>Tell your doctor right away if a pregnancy occurs while either the mother or the father is using decitabine.</p><p>This medicine may affect fertility (ability to have children) in men. However, it is important to use birth control to prevent pregnancy because decitabine can harm an unborn baby.</p><p>You should not breastfeed while using decitabine and for at least 2 weeks after your last dose.</p><h2>How is decitabine given?</h2><p>Decitabine is given as an infusion into a vein. A healthcare provider will give you this injection.</p><p>In most cases, a decitabine injection is given every 8 hours for 3 days. This 3-day treatment is usually repeated every 6 weeks at least 4 times.</p><p>You may be given other medications to prevent nausea or vomiting while you are receiving decitabine.</p><p>Decitabine affects your immune system. You may get infections more easily, even serious or fatal infections. Your doctor will need to examine you on a regular basis.</p><h2>What happens if I miss a dose?</h2><p>Call your doctor for instructions if you miss an appointment for your decitabine injection.</p><h2>What happens if I overdose?</h2><p>Since  decitabine is given by a healthcare professional in a medical setting, an overdose is unlikely to occur.</p><h2 class="ddc-anchor-offset" id="what-to-avoid">What should I avoid while receiving decitabine?</h2><p>Avoid being near people who are sick or have infections. Tell your doctor at once if you develop signs of infection.</p><p>Avoid activities that may increase your risk of bleeding or injury. Use extra care to prevent bleeding while shaving or brushing your teeth.</p><h2 class="ddc-anchor-offset" id="side-effects">Decitabine side effects</h2><p>Get emergency medical help if you have <b>signs of an allergic reaction:</b> hives; difficult breathing; swelling of your face, lips, tongue, or throat.</p><p>Call your doctor at once if you have:</p><ul>
<li>
<p>fever, chills, sore throat;</p>
</li>
<li>
<p>mouth sores, red or swollen gums, skin sores;</p>
</li>
<li>
<p>easy bruising, unusual bleeding, purple or red spots under your skin;</p>
</li>
<li>
<p>pale skin, cold hands and feet; or</p>
</li>
<li>
<p>cough with mucus, chest pain, feeling short of breath.</p>
</li>
</ul><p>fever, chills, sore throat;</p><p>mouth sores, red or swollen gums, skin sores;</p><p>easy bruising, unusual bleeding, purple or red spots under your skin;</p><p>pale skin, cold hands and feet; or</p><p>cough with mucus, chest pain, feeling short of breath.</p><p>Common side effects may include:</p><ul>
<li>
<p>fever or other signs of infection.</p>
</li>
</ul><p>fever or other signs of infection.</p><p>This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.</p><h2 class="ddc-anchor-offset" id="dosage">Decitabine dosing information</h2><p><b>Usual Adult Dose for Myelodysplastic Syndrome:</b></p><p>TREATMENT REGIMEN OPTION 1: <br/>15 mg/m2 IV over 3 hours; repeat every 8 hours for 3 days; repeat this cycle every 6 weeks; patients may be premedicated with standard antiemetic therapy <br/><br/>If hematologic recovery (ANC 1,000/mcL or greater and platelets 50,000/mcL or greater) from a previous treatment cycle requires more than 6 weeks, then the next cycle should be delayed and dosing temporarily reduced by following this algorithm:<br/>-Recovery requiring more than 6, but less than 8 weeks: Delay dosing for up to 2 weeks and temporarily reduce the dose to 11 mg/m2 IV every 8 hours (33 mg/m2/day, 99 mg/m2/cycle) when restarting therapy <br/>-Recovery requiring more than 8, but less than 10 weeks: Assess patient for disease progression (by bone marrow aspirates); in the absence of progression, the dose should be delayed up to 2 more weeks and then reduced to 11 mg/m2 IV every 8 hours (33 mg/m2/day, 99 mg/m2/cycle) when restarting therapy, then maintained or increased in subsequent cycles as clinically indicated <br/><br/>TREATMENT REGIMEN OPTION 2: <br/>20 mg/m2 IV over 1 hour; repeat daily for 5 days; repeat this cycle every 4 weeks; patients may be premedicated with standard antiemetic therapy <br/><br/>If myelosuppression is present, subsequent treatment cycles should be delayed until there is hematologic recovery (ANC 1,000/mcL or greater and platelets 50,000/mcL or greater)<br/><br/>Comments:<br/>-With either regimen, it is recommended that patients be treated for a minimum of 4 cycles; however, a complete or partial response may take longer than 4 cycles.<br/>-Perform complete blood and platelet counts prior to each cycle and as needed to monitor response and toxicity.  <br/>-Perform liver chemistries and serum creatinine prior to initiation of therapy.<br/><br/>Use: For the treatment of myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and intermediate-1, intermediate-2, and high-risk International Prognostic Scoring System groups<br/><br/></p><h2 class="ddc-anchor-offset" id="interactions">What other drugs will affect decitabine?</h2><p>Other drugs may affect decitabine, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.</p><h2>More about decitabine</h2><ul class="more-resources-list more-resources-list-general">
<li>Side Effects</li>
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Drug class: antimetabolites</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Myelodysplastic Syndrome</li>
<li>Acute Myeloid Leukemia</li>
</ul><h2>Further information</h2><p>Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.</p><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p><p class="ddc-copyright">Copyright 1996-2021 Cerner Multum, Inc. Version: 5.02.</p></body></html>